Transfusion Medicine and Hemotherapy Journal Citation Rate 2026

ISSN 1660-3796 eISSN 1660-3818 Karger Publishers CH

Q2 Quartile Open Access

About Transfusion Medicine and Hemotherapy
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Transfusion Medicine and Hemotherapy (TMH) is a peer-reviewed academic journal covering Blood donation and transfusion practices and Blood groups and transfusion, published by Karger Publishers in CH, catalogued under ISSN 1660-3796 (e-ISSN 1660-3818). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.43 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $1670 USD.

Transfusion Medicine and Hemotherapy Citation Rate 2026 — In Context

Transfusion Medicine and Hemotherapy has a 2025 2-Year Citation Rate (OpenAlex) of 1.43, placing it in the Q2 quartile within the Blood donation and transfusion practices research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Transfusion Medicine and Hemotherapy makes all articles freely available to readers for an Article Processing Charge of approximately $1670 USD.

Researchers looking to publish in Transfusion Medicine and Hemotherapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Transfusion Medicine and Hemotherapy against similar journals in the field, use our journal comparison tool.

Submission Tips for Transfusion Medicine and Hemotherapy
  • Budget $1670 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Blood donation and transfusion practices, Blood groups and transfusion, Blood transfusion and management. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Transfusion Medicine and … Compares
Citation Rate vs Field Avg
-55%
Field avg: 3.18
APC vs Field Avg
-51%
Field avg: $3390

Compared against 80 journals in the same research areas.

ISSN (Print) 1660-3796
ISSN (Online) 1660-3818
Publisher Karger Publishers
Country Switzerland
APC / Cost $1670 USD
In-depth profile & metrics

Transfusion Medicine and Hemotherapy is published by Karger Publishers and based in Switzerland. It publishes open access with an article-processing charge of USD 1670.

In our subject taxonomy, Transfusion Medicine and Hemotherapy is classified under Blood donation and transfusion practices, Blood groups and transfusion, Blood transfusion and management and Diverse Scientific and Economic Studies.

Transfusion Medicine and Hemotherapy is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 1.430.

Research Areas
Links
Frequently Asked Questions about Transfusion Medicine and Hemotherapy

Transfusion Medicine and Hemotherapy does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.430 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Transfusion Medicine and Hemotherapy is an open access journal.

The Article Processing Charge (APC) for Transfusion Medicine and Hemotherapy is $1670 USD.

Transfusion Medicine and Hemotherapy is published by Karger Publishers.

Transfusion Medicine and Hemotherapy shows strong legitimacy signals: it is indexed in DOAJ, OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Transfusion Medicine and Hemotherapy is 1660-3796. Its electronic ISSN (eISSN) is 1660-3818.

Transfusion Medicine and Hemotherapy sits in the Q2 quartile based on its latest impact factor of 1.43, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
1.430
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.430 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S44589223

Get weekly updates for Blood donation and transfusion practices journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google